Why Submit to JARS

JARS provides a focused platform for rheumatology research that connects clinical insight with immunology, imaging, and translational science. Our editorial scope covers inflammatory arthritis, connective tissue diseases, vasculitis, osteoarthritis, and rheumatology outcomes.

We value clear clinical and mechanistic insight, strong methodology, and conclusions that improve patient care and disease management.

We publish original research, reviews, short communications, methods, and data rich studies that advance rheumatology knowledge. Manuscripts receive expert handling by editors and reviewers who understand the rigor needed for clinical trials, registries, translational studies, and outcomes reporting.

We welcome collaborative studies that bridge laboratory discovery with clinical decision making and long term patient outcomes.

Open access publication ensures rapid visibility, global readership, and practical impact. For authors seeking to maximize citations, funder compliance, and research reuse, JARS offers clear scope alignment and a professional publishing experience.

Manuscript Readiness and Research Quality

Strong JARS submissions present a clear clinical or mechanistic hypothesis, rigorous methods, and transparent reporting. Whether you are describing clinical trials, observational cohorts, registries, or translational studies, we recommend clear study design statements and complete methodological detail so reviewers can evaluate reproducibility.

Figures and tables should communicate outcomes with precision. Use high resolution images, report sample sizes, effect sizes, and statistical tests, and include appropriate controls. Data availability statements should describe repositories, accession numbers, or how readers can access supporting datasets.

For studies involving human participants, biospecimens, or animal models, include ethics approval identifiers and compliance statements. We also welcome pre registered studies and encourage structured reporting standards when available for your research area.

Editorial Workflow and Visibility

After submission, manuscripts receive an editorial assessment and are assigned to subject editors for peer review. Our goal is to deliver a timely first decision while maintaining rigorous evaluation standards.

Accepted articles are professionally produced in HTML, PDF, and XML formats and are integrated with DOI registration and indexing metadata. This ensures your work is discoverable through academic search engines and citation networks.

Authors receive clear status updates at key stages, and revision guidance focuses on scientific clarity, data integrity, and rheumatology significance. Once published, articles are promoted through journal channels to increase visibility across academic, clinical, and industry audiences.

JARS welcomes thematic special issues in emerging rheumatology areas. If you are organizing a research community or conference track, contact us about proposing a special issue or serving as a guest editor.